Sermorelin acetate
- CAS NO.:114466-38-5
- Empirical Formula: C149H246N44O42S
- Molecular Weight: 3357.91
- MDL number: MFCD08277636
- EINECS: 466-138-5
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-01-27 18:41:44
What is Sermorelin acetate?
Description
Sermorelin acetate, also known as INN/Geref/Gerel, is a peptide analogue of growth hormone-releasing hormone (GHRH) used as a diagnostic agent to evaluate growth hormone (GH) secretion and diagnose growth hormone deficiency. It is a 29 amino acid polypeptide representing fragments 1-29 from endogenous human GHRH and is considered to be the shortest fully functional fragment of GHRH.
The Uses of Sermorelin acetate
Sermorelin acetate is used as a diagnostic agent to assess growth hormone (GH) secretion. It is also used as doping agent in sports due to its correlation with increased growth of muscular and skeletal tissue. Sermorelin use is also hypothesized to improve deep rapid eye movement sleep.
Benefits
The benefits of using Sermorelin acetate therapy are multifaceted and include: helping to increase muscle strength, weight loss, improved bone mineral density, improved cognitive health, increased energy levels, restoration of sexual dysfunction, improvement of cardiovascular disease, enhancement of the immune system, improvement of skin health, and a boost in metabolism.
Side Effects
All medicines may cause side effects, but many have no or minor side effects. The most common side effects:
Facial flushing; headache; nausea; pain, redness, or swelling at the injection site; paleness; strange taste in mouth; vomiting.
The Severe side effects :
Severe allergic reactions (rash, hives, itching, difficulty breathing, tightness in the chest, swelling of the mouth, face, lips, or tongue).
References
Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats DOI: 10.1016/0196-9781(93)90101-L
Comparison of GH-stimulation by GH-RH(1-29)NH2 and an agmatine29 GH-RH analog, after intravenous, subcutaneous and intranasal administration and after pulmonary inhalation in rats DOI: 10.1111/j.1399-3011.1993.tb00332.x
Potent agonists of growth hormone-releasing hormone Part I DOI: 10.1111/j.1399-3011.1992.tb00791.x
Synthesis and in vitro and in vivo activity of analogs of growth hormone-releasing hormone (GH-RH) with C-terminal agmatine DOI: 10.1111/j.1399-3011.1990.tb00988.x
Growth-hormone-releasing hormone DOI: 10.1093/clinchem/36.3.415
Properties of Sermorelin acetate
| storage temp. | 0 - 4 °C for short term, or -20 °C for long term |
| solubility | Soluble in DMSO, not in water |
Safety information for Sermorelin acetate
Computed Descriptors for Sermorelin acetate
| InChIKey | WGWPRVFKDLAUQJ-PUMMXPSGNA-N |
New Products
Tetrabutylammonium perchlorate DL-beta-(3-Bromophenyl)alanine N,N CARBONYL DIIMIDAZOLE 2-Amino-5-bromo-4-(trifluoromethyl)pyridine(RM for Indian lab) (RS)-beta-Amino-beta-(4-bromophenyl)propionic acid (R)-1-Benzyl-3-pyrrolidinecarbonitrile Rifaximin EP Impurity-G N-Nitroso hydroxy Cetrizine EP Impurity-A Noradrenaline EP Impurity D/Noradrenaline Methyl Ether Cetirizine EP Impurity A/Cetirizine CBHP Impurity Lantanoprost rc B Clidinium Bromide Impurity 2,2'-(5-methyl-1,3-phenylene)-di(2-Methylpropionitrile) 1-methyl amino-2,4-dinitro benzene 5-Methyl-1,3-benzenediacetonitrile 4-Fluorothiophenol (R)-BoroLeu-(+)-Pinanediol-CF3COOH 4-(5-amino-1-methyl-1h-benzoimidazol-2-yl)-butyric acid isopropyl ester. 2-Chloro Benzylcyanide 3-chlorobenzyl cyanide 3,4 Diethoxy Benzylcyanide 3,4 Dimethoxy Benzylcyanide valeronitrile 4-Bromo BenzylcyanideRelated products of tetrahydrofuran







You may like
-
Bendamustine deschloroethyl acid ethyl ester 2517968-40-8 NLT 95%View Details
2517968-40-8 -
Acebutolol EP Impurity K NLT 95%View Details
74143-33-2 -
Clidinium Bromide Impurity NLT 95%View Details
.6581-06-2 -
192110-67-2 NLT 95%View Details
192110-67-2 -
Cetirizine EP Impurity A/Cetirizine CBHP Impurity NLT 95%View Details
59872-62-1 -
90717-17-2 Ketamine Impurity-C NLT 95%View Details
90717-17-2 -
.2005-04-1 N-Nitroso hydroxy Cetrizine EP Impurity-A NLT 95%View Details
.2005-04-1 -
145773-22-1 Lantanoprost rc B NLT 95%View Details
145773-22-1
